The use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria

The aim of the study was to study trigger factors in chronic urticaria, peculiarities in the expression of Toll-like receptors, clinical and immunological efficacy of microbial antigens in patients with chronic urticaria.Materials and methods. Patients with chronic urticaria (134 patients). A study...

Full description

Bibliographic Details
Main Authors: E. V. Sorokina, N. G. Sivakova, E. A. Akhmatova, N. N. Mitrofanova, S. A. Shodova, N. K. Akhmatova
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2019-11-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.elpub.ru/jour/article/view/471
_version_ 1811285285509529600
author E. V. Sorokina
N. G. Sivakova
E. A. Akhmatova
N. N. Mitrofanova
S. A. Shodova
N. K. Akhmatova
author_facet E. V. Sorokina
N. G. Sivakova
E. A. Akhmatova
N. N. Mitrofanova
S. A. Shodova
N. K. Akhmatova
author_sort E. V. Sorokina
collection DOAJ
description The aim of the study was to study trigger factors in chronic urticaria, peculiarities in the expression of Toll-like receptors, clinical and immunological efficacy of microbial antigens in patients with chronic urticaria.Materials and methods. Patients with chronic urticaria (134 patients). A study of the expression of TLR2, TLR3, TLR4, TLR9 on blood cells using flow cytometry. 62 patients received polyvalent bacterial lysate against baseline therapy per os, 72 patients received monotherapy with basic drugs.Results. In patients with bacterial infection, high levels of TLR2, TLR4 expression were detected. In the presence of viral infections, high TLR3 expression values were observed. The use of PBL contributed to an increase in the number of patients with clinical remission, decreased urticaria activity, led to a correction in TLR2 and TLR4, and decreased the level of total IgE.Conclusion. Inclusion in the complex of therapeutic and prophylactic measures in patients with urticaria of a chronic drug based on microbial antigens (polyvalent bacterial lysate) contributes to the increase of clinical effectiveness and activation of the links of innate immunity.
first_indexed 2024-04-13T02:41:52Z
format Article
id doaj.art-1b296f492a344428b28e6c926d2dd131
institution Directory Open Access Journal
issn 0372-9311
2686-7613
language Russian
last_indexed 2024-04-13T02:41:52Z
publishDate 2019-11-01
publisher Central Research Institute for Epidemiology
record_format Article
series Журнал микробиологии, эпидемиологии и иммунобиологии
spelling doaj.art-1b296f492a344428b28e6c926d2dd1312022-12-22T03:06:10ZrusCentral Research Institute for EpidemiologyЖурнал микробиологии, эпидемиологии и иммунобиологии0372-93112686-76132019-11-0105343910.36233/0372-9311-2019-5-34-39439The use of a polyvalent bacterial lysate in a complex therapy of chronic urticariaE. V. Sorokina0N. G. Sivakova1E. A. Akhmatova2N. N. Mitrofanova3S. A. Shodova4N. K. Akhmatova5Mechnikov Research Institute of Vaccines and Sera; Academy of Postgraduate Education of FMBAMechnikov Research Institute of Vaccines and SeraMechnikov Research Institute of Vaccines and SeraMedical Institute of Penza State UniversityMechnikov Research Institute of Vaccines and SeraMechnikov Research Institute of Vaccines and SeraThe aim of the study was to study trigger factors in chronic urticaria, peculiarities in the expression of Toll-like receptors, clinical and immunological efficacy of microbial antigens in patients with chronic urticaria.Materials and methods. Patients with chronic urticaria (134 patients). A study of the expression of TLR2, TLR3, TLR4, TLR9 on blood cells using flow cytometry. 62 patients received polyvalent bacterial lysate against baseline therapy per os, 72 patients received monotherapy with basic drugs.Results. In patients with bacterial infection, high levels of TLR2, TLR4 expression were detected. In the presence of viral infections, high TLR3 expression values were observed. The use of PBL contributed to an increase in the number of patients with clinical remission, decreased urticaria activity, led to a correction in TLR2 and TLR4, and decreased the level of total IgE.Conclusion. Inclusion in the complex of therapeutic and prophylactic measures in patients with urticaria of a chronic drug based on microbial antigens (polyvalent bacterial lysate) contributes to the increase of clinical effectiveness and activation of the links of innate immunity.https://microbiol.elpub.ru/jour/article/view/471chronic urticariatoll-like receptorspolyvalent bacterial lysate
spellingShingle E. V. Sorokina
N. G. Sivakova
E. A. Akhmatova
N. N. Mitrofanova
S. A. Shodova
N. K. Akhmatova
The use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria
Журнал микробиологии, эпидемиологии и иммунобиологии
chronic urticaria
toll-like receptors
polyvalent bacterial lysate
title The use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria
title_full The use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria
title_fullStr The use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria
title_full_unstemmed The use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria
title_short The use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria
title_sort use of a polyvalent bacterial lysate in a complex therapy of chronic urticaria
topic chronic urticaria
toll-like receptors
polyvalent bacterial lysate
url https://microbiol.elpub.ru/jour/article/view/471
work_keys_str_mv AT evsorokina theuseofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT ngsivakova theuseofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT eaakhmatova theuseofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT nnmitrofanova theuseofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT sashodova theuseofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT nkakhmatova theuseofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT evsorokina useofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT ngsivakova useofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT eaakhmatova useofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT nnmitrofanova useofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT sashodova useofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria
AT nkakhmatova useofapolyvalentbacteriallysateinacomplextherapyofchronicurticaria